Share Search
Visit the Share Search
Diaceutics Accounts Summary
| Date of Accounts | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
| Revenue | 19.50 | 13.94 | 12.70 | 13.44 | 10.37 |
| Operating Profit / Loss | 0.57 | 0.55 | -0.66 | -0.74 | 1.20 |
| Net Interest | -0.01 | -0.09 | -0.02 | -0.24 | -0.32 |
| Pre Tax Profit | 0.56 | 0.46 | -0.68 | 0.50 | 0.88 |
| Post Tax Profit | 0.72 | 0.56 | 0.26 | 0.40 | 0.63 |
| Profit for the Period | 0.72 | 0.56 | 0.26 | 0.40 | 0.63 |
| Equity Holders of Parent Company | 0.72 | 0.56 | 0.26 | 0.40 | 0.63 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | 0.86p | 0.67p | 0.34p | 0.62p | 1.41p |
| Earnings per Share (Diluted) | 0.84p | 0.66p | 0.34p | 0.62p | 1.41p |
| Earnings per Share (Adjusted) | 0.86p | 0.67p | 0.74p | 2.46p | 1.86p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 0.86p | 0.67p | 0.34p | 0.62p | 1.41p |
| Earnings per Share (Diluted) | 0.84p | 0.66p | 0.34p | 0.62p | 1.41p |
| Earnings per Share (Adjusted) | 0.86p | 0.67p | 0.74p | 2.46p | 1.86p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
| Non-Current Assets | |||||
| Intangible Assets | 15.22 | 12.82 | 9.36 | 3.76 | 1.21 |
| Property, Plant and Equipment | 2.09 | 2.13 | 0.24 | 0.13 | 0.07 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | 0.05 | 0.00 | 0.30 | 0.06 | 0.06 |
| Total Non-Current Assets | 17.36 | 14.95 | 9.90 | 3.95 | 1.35 |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | 11.06 | 10.39 | 6.11 | 6.64 | 4.39 |
| Cash at Bank and in Hand | 19.84 | 19.68 | 25.25 | 11.72 | 2.07 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | n/a | n/a | 2.26 | 0.07 | n/a |
| Total Current Assets | 30.90 | 30.06 | 33.62 | 18.42 | 6.46 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 48.26 | 45.01 | 43.52 | 22.37 | 7.81 |
| Current Liabilities | |||||
| Borrowings | 0.12 | 0.28 | 0.12 | 0.11 | 2.72 |
| Other Current Liabilities | 3.63 | 2.36 | 2.80 | 2.13 | 1.22 |
| Total Current Liabilities | 3.75 | 2.63 | 2.91 | 2.24 | 3.93 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 1.21 | 1.28 | n/a | n/a | 1.07 |
| Provisions | 0.79 | 0.44 | 0.37 | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | 0.18 |
| Total Non-Current Liabilities | 1.99 | 1.73 | 0.37 | n/a | 1.25 |
| Net Assets | 42.51 | 40.65 | 40.24 | 20.13 | 2.63 |
| Capital and Reserves | |||||
| Share Capital | 0.17 | 0.17 | 0.17 | 0.14 | n/a |
| Share Premium Account | 37.13 | 36.86 | 36.86 | 17.34 | 0.10 |
| Other Reserves | -0.12 | -0.47 | 0.01 | 0.02 | 0.29 |
| Retained Earnings | 5.34 | 4.08 | 3.19 | 2.64 | 2.24 |
| Shareholders Funds | 42.51 | 40.65 | 40.24 | 20.13 | 2.63 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 42.51 | 40.65 | 40.24 | 20.13 | 2.63 |
| 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 | |
| Operating Margin | 2.95% | 3.94% | -5.20% | -5.51% | 11.58% |
| Return on Capital Employed | 1.96% | 1.84% | -2.10% | 4.49% | 23.09% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | 87.80 | 152.20 | 180.40 | 41.50 | n/a |
| PEG | n/a | n/a | 18.00 | 0.20 | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 32.31p | 32.94p | 36.55p | 19.38p | 1.68p |